Well Lead Medical Co., Ltd. (SHA:603309)

China · Delayed Price · Currency is CNY

11.51

+0.01 (0.09%)

Jun 18, 2026, 3:00 PM CST

-7.92% (1Y)

Market Cap	3.36B -7.5%
Revenue (ttm)	1.64B +5.9%
Net Income	77.35M -66.1%
EPS	0.27 -66.0%
Shares Out	291.87M
PE Ratio	43.31
Forward PE	10.65
Dividend	0.60 (5.10%)
Ex-Dividend Date	May 28, 2026

Volume	3,296,930
Open	11.48
Previous Close	11.50
Day's Range	11.46 - 11.72
52-Week Range	11.21 - 16.42
Beta	-0.21
Analysts	Buy
Price Target	n/a
Earnings Date	Jul 24, 2026

About Well Lead Medical

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, urethral and ureteral dilation, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation acc... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1998

Employees 2,849

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603309

Full Company Profile

Financial Performance

In 2025, Well Lead Medical's revenue was 1.63 billion, an increase of 8.07% compared to the previous year's 1.51 billion. Earnings were 76.33 million, a decrease of -65.21%.

Financial Statements